Well you make a good point IF you think Titan's current market cap is a reflection of Titan's current true value. I think many Titan investors would argue the IP behind SPORT is worth significantly more than the current market cap. Transenterix has a couple pieces of $hit and they are able to hold up fairly well. Again, Titan is a public company and the development has been publicly funded. I dont get you guys that get your panties in a bunch over investors that just want to see Titan's value grow steadily. SPORT should be sold at a premium. We will not ever see that premium if this stock doesnt see a healthy gain. We will never see that healthy gain until institutional investors are able to get in. Institutional investors wont get in until Titan uplists. I dont know about you but I prefer this company sell before any of the other legitimate contenders make it to market. Titan going it alone after FDA clearance is not the ideal scenario, period.
News 
Market Data 
Discover 
AI
